AI Could Revolutionize Gene Therapy • MedicalExpo e-Magazine

Artificial intelligence could revolutionize gene therapy and precision medicine, making individualized treatment protocols the norm. When research began on the human genome in the early 1990s, many doctors anticipated an age of precision medicine (PM), with patients taking highly customized drugs targeting the specific genetic drivers of their disease or condition. Today, as artificial intelligence (AI) and machine learning (ML) play a greater role in gene therapy, one-size-fits-all medicine is on the way out. After years of setbacks, gene therapy is now generating headlines for all the right reasons. In March 2017, it was announced that a French teenager had been cured of sickle-cell disease after receiving gene therapy in 2015.